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Fen-yu Jin,* Carl Nathan,* Danuta Radzioch,† SAPK, and ceramide-activated kinase), other serine/
threonine kinases (such as Raf, protein kinase C, andand Aihao Ding*
*Beatrice and Samuel A. Seaver Laboratory protein kinase A), GTPases (such as ras), and transcrip-
tion factors (such as NF-kB) (Sweet and Hume, 1996).Department of Medicine
Cornell University Medical College Cytokines can enhance (IFNg) or suppress (TGFb, IL-10,
IL-4, IL-11, IL-13) the macrophage’s response to LPS.New York, New York 10021
†Department of Medicine In mice, responsiveness to LPS is controlled by an
unidentified gene located on chromosome 4. A defectMcGill University
Montreal, Quebec H3G 1A4 in this locus in C3H/HeJ mice confers LPS resistance
(Sultzer, 1968; Watson et al., 1978; Sultzer et al., 1993).Canada
Compared to an ostensibly congenic strain, C3H/HeN,
which carries normal alleles (Lpsn ) of the Lps gene, C3H/
HeJ (Lpsd ) mice are hyporesponsive to LPS, a pheno-Summary
type expressed in macrophages, B lymphocytes, T lym-
phocytes, and fibroblasts (Rosenstreich and Glode,To explore regulation of potentially lethal responses
1975; Sultzer, 1976; Beutler et al., 1986a). Moreover,to bacterial lipopolysaccharide (LPS), we used differ-
C3H/HeJ mice survive injection of LPS at doses 20–40ential display under LPS-free conditions to compare
times higher than those lethal to C3H/HeN mice (Sultzer,macrophage cell lines from two strains of mice
1968). The LPS defect in C3H/HeJ mice is not absolute,congenic for a locus affecting LPS sensitivity. LPS-
since certain partial responses are preserved under thehyporesponsive cells, primary macrophages, and
usual conditions of stimulation (Coutinho et al., 1975),polymorphonuclear leukocytes transcribed secretory
while others are evoked by higher concentrations of, orleukocyte protease inhibitor (SLPI), a known epithelial
after longer exposures to, LPS (Sultzer, 1968; Ding et al.,cell-derived inhibitor of leukocyte serine proteases.
1995). Strikingly, coadministration of interferon-g (IFNg)Transfection of macrophages with SLPI suppressed
normalizes the LPS responsiveness of C3H/HeJ miceLPS-induced activation of NF-kB and production of
(Beutler et al., 1986b). The mechanism of compensationnitric oxide and TNFa. The ability of interferon-g (IFNg)
by IFNg is as obscure as the biochemical basis of theto restore LPS responsiveness is a hallmark of the
defect itself.LPS-hyporesponsive phenotype. IFNg suppressed ex-
In an effort to learn more about regulation of respon-pression of SLPI and restored LPS responsiveness to
siveness to LPS, we carried out differential display anal-SLPI-producing cells. Thus, SLPI is an LPS-induced
ysis (Liang and Pardee, 1992) on matched macrophageIFNg-suppressible phagocyte product that serves to
cell lines from C3H/HeJ and C3H/HeN mice. We rea-inhibit LPS responses.
soned that differential display should be unbiased with
respect to whether the defect in the hyporesponsiveIntroduction
strain represents extinction of an LPS response media-
tor or overexpression of an LPS response inhibitor. WeEndotoxic lipopolysaccharide (LPS), the major constit-
compared cultured cell lines as one of the only secureuent of the cell walls of Gram-negative bacteria, is
routes to studying genes whose expression differs inamong the most potent substances in biology. A few
the absence of LPS, a stimulus to which most primarymolecules per cell can trigger macrophages, the most
macrophages in conventionally reared mice can be pre-LPS-responsive cells in the mammalian host, to release
sumed to have been exposed. Described below is thea battery of alarm signals and defense molecules, in-
cloning of cDNA for secretory leukocyte protease inhibi-cluding TNFa, IL-1, IL-12, migration inhibitory factor
tor (SLPI), a gene overexpressed in a C3H/HeJ (Lpsd )(MIF), chemokines, interferons, eicosanoids, and reac-
macrophage cell line but inducible by LPS in wild-typetive oxygen and nitrogen intermediates (Ding and Na-
macrophages and neutrophils, and suppressible bythan, 1987; Nathan, 1987). The macrophage secretory
IFNg. The SLPI gene product is a protein that was pre-response to LPS can protect the host from infection,
viously well studied to the point of structural solution,but can also cause tissue injury, cachexia, circulatory
and yet about which it was not knownthat macrophagescollapse, multiple organ failure, and death (Parker and
produce it, that its production is regulated by LPS andParrillo, 1983; Bone, 1991). Thus, both biological and
IFNg, and that its actions include antagonism of LPS-medical questions motivate inquiry into the regulation
induced signaling and secretion.of responses to LPS.
More is known about stimulation of LPS responses
than about their inhibition. LPS binding protein (Tobias Results
et al., 1986) catalyzes the formation of complexes of
LPS with the glycophosphatidyl inositol-linked receptor, SLPI Is Constitutively Overexpressed in a
Macrophage Cell Line from C3H/HeJCD14 (Wright et al., 1990). These complexes interact
with an unidentified coreceptor (Ulevitch and Tobias, (Lpsd ) but Not C3H/HeN (Lpsn) Mice
We compared gene expression patterns in macrophage1995) to activate tyrosine kinases, proline-directed ser-
ine/threonine kinases (such as ERK1, ERK2, p38a, cell lines, cultured under LPS-free conditions, which
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Figure 1. Identification of a Gene (SLPI) Over-
expressed in LPS-Hyporesponsive GG2EE
(Lpsd ) Cells Compared to LPS-Normorespon-
sive HeNC2 (Lpsn ) Cells
(A) Differential responsiveness of HeNC2
(Lpsn ) and GG2EE (Lpsd ) cells to LPS. Cells
(105 per well) were treated for 24 hr with or
without 1 ng/ml of LPS andTNFa in the super-
natants determined by ELISA. Results are
means 6 SEM of triplicates from one of four
similar experiments.
(B) Examples of differential display (left panel)
using as one primer either T1 (AGCCAGC
GAA), T2 (CAAAGGGAGA), T3 (GAAGTGG
TTT), T4 (CAGTCAACCT), T5 (CTCAACCTCC),
or T6 (CTGATCCATG), and T12MA as the
other. In each pair of lanes, the left (H) is
amplified from HeNC2 (Lpsn ) cells and the
right (G) from GG2EE (Lpsd ) cells. In the right
panel, SLPI (marked by arrow) was amplified
only from GG2EE (Lpsd ) cells using the prim-
ers ACCATGGACT and T12MC.
(C) Northern blot with total RNA (20 mg) from
HeNC2 (Lpsn ) and GG2EE (Lpsd ) cells probed
with mouse SLPI cDNA fragment isolated by
differential display, confirming its differential
expression. The same membrane was rehy-
bridized with a b-actin oligonucleotide probe
as a loading control.
were derived from two mouse strains believed to be Lps pression in GG2EE (Lpsd) cells than in HeNC2 (Lpsn )
cells (Figure 1C).congenics: C3H/HeN (Lpsn ) (HeNC2 cells) and C3H/HeJ
(Lpsd) (GG2EE cells). These cell lines maintain the LPS-
responsive (HeNC2) or LPS-hyporesponsive (GG2EE) Cloning of Mouse SLPI
The subcloned cDNA fragment of mouse SLPI was usedphenotypes of their parental cells with respect to LPS-
induced cytotoxicity toward L5178Y target cells and as probe to screen a cDNA library from IFNg- and LPS-
activated RAW 264.7 cells, an Abelson–virus trans-LPS-induced TNFa release (Blasi et al., 1987) (Figure
1A). Each primer set for differential display consisted of formed murine macrophage cell line. This previously
prepared library (Xie et al., 1992) was used even thougha random 10-mer and a T12M(C, G, T, A), where M stands
for the mixture of C, G, A. About 50–100 amplification RAW 264.7 cells respond normally to LPS and express
much less SLPI than GG2EE cells, as documentedproducts from one PCR reaction were distinguishable
on a 5% polyacrylamide gel. As illustrated for seven below. The full-length 1123 bp mouse SLPI cDNA was
comprised of a 59 untranslated region (nucleotidesprimer sets in Figure 1B, more than 99.75% of 12,000
such products were shared by the HeNC2 (Lpsn ) and 1–446), open reading frame (447–842), and 39 untrans-
lated region (843–1123). Overall homology with humanGG2EE (Lpsd) cells. Only four mRNAs (two in each of the
cell lines) were consistently expressed in a differential SLPI (Thompson and Ohlsson, 1986) is 68% at the nucle-
otide level and 60%at the amino acid level (Figure 2).Themanner in multiple replicate experiments. The present
study concerns a transcript amplified with the primer signal peptides are particularly well conserved (80%). In
contrast, the secreted proteins are only 52% identical.set ACCATGGACT and T12MC that was expressed only
by GG2EE (Lpsd ) cells and not by HeNC2 (Lpsn ) cells. However, all 16 cysteine residues are preserved.
This amplification product was isolated, reamplified,
cloned, and sequenced. The primer sequences flanked Cell Lines That Overexpress SLPI Are
Hyporesponsive to LPSa previously unreported reading frame that was 68%
homologous to human SLPI. Northern blot analysis with Since GG2EE (Lpsd ) cells express SLPI and resist LPS,
while HeNC2 (Lpsn ) cells express almost no SLPI andthe mouse SLPI probe confirmed a higher level of ex-
SLPI as an LPS Inhibitor
419
Figure 2. Amino Acid Sequence Comparison
between Mouse and Human SLPI
Translated amino acid sequence of mouse
(Mo) SLPI is aligned with human (Hu) SLPI.
Conserved residues are shaded; Cys are
boxed. The binding region for proteases is
underlined and the reactive site is double-
underlined with boldface marking the substi-
tution of Leu (human) with Met (mouse).
respond to LPS, we compared levels of SLPI transcript tion with antibody raised against recombinant mouse
SLPI. RAW 264.7 and ANA-1 cells expressed as littleand protein with sensitivity to LPS in three additional
macrophage cell lines from other genetic backgrounds SLPI mRNA and secreted as little SLPI protein as HeNC2
(Lpsn ) cells. As shown earlier, GG2EE (Lpsd) cells ex-(ANA-1, C57BL/6; RAW 264.7 and J774.1, BALB/c) (Fig-
ure 3). Secreted SLPI was detected by immunoprecipita- pressed a high level of SLPI mRNA; in addition, they
Figure 3. Relationship between Expression
of SLPI and Production of NO and TNFa in
Response to LPS in HeNC2 (Lpsn ), GG2EE
(Lpsd ), RAW 264.7, ANA-1, and J774.1 Cells
(A) Upper: Northern blot (20 mg RNA) probed
with SLPI cDNA. The same membrane was
reprobed with a b-actin oligonucleotide as a
loading control. Lower: Immunoblot of SLPI
in the medium of cultures of the indicated
cells after immunoprecipitation with rabbit-
anti-mouse-SLPI serum.
(B) NO production in response to LPS.
HeNC2(j), GG2EE(d), ANA-1(m), RAW264.7
(r), and J774.1(.) cells (105 per well) were
exposed to LPSfor 48 hr. Nitrite accumulation
from the conditioned media was determined.
Results are means of triplicates. Error bars
indicating SEM fall within the symbols. One
of five similar experiments is shown.
(C) TNFa production in response to LPS.Cells
as in (B) were exposed to LPS for 12 hr. TNF
content in the supernatants was determined




secreted abundant SLPI protein. J774.1 expressed an
intermediate level of SLPI mRNA, but secreted the most
protein of the five macrophage lines tested (Figure 3A).
Reciprocally, HeNC2, ANA-1, and RAW 264.7 cells (all
Lpsn ) responded to as little as 10 ng/ml LPS by releasing
20- to 40-fold more NO and TNFa than they secreted
spontaneously. By the same criteria, GG2EE (Lpsd) and
J774.1 cells were LPS-resistant (Figures 3B and 3C).
Although J774.1 cells released some NO and TNF in
the absence of LPS, the amount scarcely changed with
increasing concentrations of LPS.
Transfection with SLPI Converts Macrophages
from LPS-Sensitive to LPS-Hyporesponsive
The inverse correlation between SLPI expression and
LPS hyporesponsiveness among five macrophage cell
lines prompted us to test whether expression of SLPI
causes LPS hyporesponsiveness. HeNC2 (Lpsn ) cells
were transfected with the p463-neo control vector or
the same vector containing the SLPI open reading frame
(p436-neo-SLPI). Stably transfected clones were pheno-
typed by Northern and Western analyses. HeNC2-C2C7
(transfected with p463-neo vector only) expressed no
SLPI, while the independently selected clones HeNC2-
C6C10 and HeNC2-D4F9 (both transfected with p436-
neo-SLPI) expressed equivalent levels of SLPI mRNA
and protein as GG2EE (Lpsd) cells (Figure 4A). LPS re-
sponsiveness, judged by induction of secretion of NO
and TNFa, was preserved in HeNC2-C2C7 cells (control
vector-transfected), just as in the parental HeNC2 (Lpsn )
cells. In contrast, the two SLPI transfectants became
markedly LPS hyporesponsive, requiring 100-fold more Figure 4. Inhibition of LPS- but not IFNg-Signaling in SLPI-Overex-
LPS to produce the same amounts of the LPS-response pressing Clones
products as the parental cells (Figure 4B). (A) Upper: Expression of SLPI mRNA by stable clones of HeNC2
cells (Lpsn ) transfected with p463-neo (HeNC2-C2C7) or with p463-To evaluate signaling by LPS, we performed electro-
neo-SLPI (HeNC2-C6C10 and HeNC2-D4F9) in comparison to pa-phoretic mobility shift assays with an NF–kB binding
rental HeNC2 cells (Lpsn ) and GG2EE cells (Lpsd ). Northern blot withelement shown to be essential for LPS to induce tran-
SLPI cDNA as a probe. Total RNA (20 mg) was loaded in each
scription of the high-output form of nitric oxide synthase lane with ethidium bromide staining to control for loading. Lower:
(iNOS; NOS2) (Xie et al., 1994). As little as 100 pg/ml Secretion of SLPI. SLPI was immunoprecipitated with rabbit-anti-
SLPI antibody from culture medium and immunoblotted with theLPS activated NF-kB in parental HeNC2 (Lpsn ) cells and
same antibody.in mock-transfected cells, but LPS failed to do so in
(B) LPS-responsiveness of HeNC2(n), GG2EE(s), HeNC2-C2C7(m),GG2EE (Lpsd ) cells or in the two SLPI transfectants of
HeNC2-C6C10(d), and HeNC2-D4F9(h) in (A) judged by LPS-in-
HeNC2 (Figure 4C). The inhibitory effect of SLPI on LPS duced release of nitrite (48 hr) or TNFa (12 hr) as in the legend
signaling appears to be specific, since overexpression to Figure 3B. Results are means 6 SEM from one of five similar
experiments.of SLPI had no effect on IFNg-induced DNA-binding
(C) Cells were treated with 0, 0.1, or 1 ng/ml of LPS (upper) or 0,activity to a gamma response region (GRR) present in
0.1, 1, or 10 U/ml of IFNg (lower) for 30 min. NF-kB (upper) or GRRthe promoter of the Fcg receptor (Pearse et al., 1991)
(lower) activity in nuclear extracts was determined by EMSA. Arrows
(Figure 4C). indicate position of NF-kB heterodimers and GRR binding complex.
Restoration of LPS Responsiveness in SLPI-High Expression of SLPI in Primary Macrophages,
Expressor Cells upon Treatment with IFNg Polymorphonuclear Leukocytes, and Organs
The ability of IFNg to restore LPS responsiveness is a The work to this point was centered on cultured cell
hallmark of the defect in C3H/HeJ mice (Beutler et al., lines for two reasons: scrupulously to avoid exposure
1986b). As shown in Figure 5A, IFNg restored LPS- to LPS prior to its addition as a reagent at defined con-
induced NO and TNFa production in GG2EE (Lpsd) cells. centrations, and to permit transfection of candidate reg-
Likewise, IFNg shifted the LPS concentration–response ulatory genes into the cells under study. Next, we turned
curve for NO production to the left by two to three orders to primary cells from C3H/HeN (Lpsn ) and C3H/HeJ
of magnitude in each of the two independently derived (Lpsd )mice. SLPI mRNA was detected in peritoneal mac-
SLPI transfectants (Figure 5B), as well as for TNFa pro- rophages from both strains of mice elicited by intraperi-
toneal injection of thioglycollate broth (Figure 6A). As isduction (data not shown).
SLPI as an LPS Inhibitor
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Figure 5. Restoration of LPS Responses in SLPI-Expressing Cells
by IFNg
(A) GG2EE cells (Lpsd ) were incubated in the presence (n) or ab-
sence (m) of IFNg (10 units/ml) along with the indicated concentra-
tions of LPS and accumulation of nitrite (left panel) or TNFa (right
panel) measured at 24 hr.
(B) Two SLPI-expressing transfectants, HeNC2-C6C10 (d,s) and
HeNC2-D4F9 (j,h), were treated with (s,h) or without (d,j) IFNg
as in (A), and nitrite accumulation was measured. In all four panels
Figure 6. Modulation of SLPI Expression by LPS in Primary Macro-results are means of triplicates from one of four similar experiments.
phages and PMNMost of the bars indicating SEM fall within the symbols.
(A) Peritoneal macrophages were collected from from C3H/HeN
(Lpsn ) or C3H/HeJ (Lpsd) mice four days after injection of LPS-
contaminated thioglycollate broth and not further treated (0 hr) or
cultured with 100 ng/ml of LPS for the indicated times before totaloften the case, the thioglycollate broth used to elicit
RNA was analyzed by northern blot using SLPI cDNA as probethese macrophages was contaminated with LPS (z0.5
(48 hr exposure). The same membrane was reblotted using b-actinng/ml). In vitro, reagent LPS increased the expression
oligonucleotide probe as a control.
of SLPI mRNA in C3H/HeN (Lpsn ) macrophages at 6 and (B) Expression of SLPI transcripts in 20 mg of total RNA from organs
18 hr. Although no increase in SLPI mRNA expression of C3H/HeN (Lpsn ) mice four days after intraperitoneal injection of
was detected in C3H/HeJ (Lpsd) macrophages at 6 hr, thioglycollate broth with SLPI cDNA as probe.
(C) Expression of SLPI in PMN. PMN were collected from peritonealit became apparent by 18 hr (Figure 6A).
cavity of C3H/HeN (Lpsn ) mice at 12 hr following injection of thiogly-Next, we looked at organsof C3H/HeN (Lpsn ) mice that
collate broth. PMN were treated with 0 or 100 ng/ml LPS for 4 hr.had been injected intraperitoneally with thioglycollate
Six micrograms total RNA was probed with mouse SLPI cDNA.broth and thus with LPS. Mouse SLPI mRNA was ex-
pressed not only in lung, as previously noted for human
SLPI (De Water et al., 1986; Sallenave et al., 1993), but
of LPS-contaminated thioglycollate broth, and their ex-also in spleen (Figure 6B). No SLPI transcripts were
pression of SLPI increased further upon additional treat-detected in liver, brain, kidney, or heart. When spleno-
ment for 4 hr with LPS in vitro, but not with formylatedcytes were isolated, the nonadherent, lymphocyte-rich
peptide (Figure 6C).fraction showed little SLPI expression. Neither conca-
SLPI mRNA was detected in tissue, primary macro-navalin A, a T cell mitogen, nor LPS, a B cell mitogen,
phages, PMN, and the ANA-1 and RAW 264.7 cell linesinduced SLPI in lymphocytes (data not shown). In con-
as a single species of 850 nt (Figures 3A, 6, and 7),trast, the other major class of phagocytes, i.e., polymor-
whereas it appeared as a doublet of 850 and 1200 nt inphonuclear leukocytes (PMN), expressed SLPI mRNA
after inflammation of the peritoneal cavity by injection HeNC2 (Lpsn ), GG2EE (Lpsd ), and J774.1 cells (Figures
Cell
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Whether human phagocytes likewise express SLPI is
being reexamined.
Though the overall amino acid identity of mature
mouse and human SLPI is only 52%, there are striking
structural similarities. X-ray diffraction analysis of hu-
man SLPI revealed a boomerang-shaped molecule com-
prised of two topologically superimposable domains
(Ser1–Pro54 and Asn55–Ala107) (Grutter et al., 1988). Mouse
SLPI can likewise be envisioned as comprised of two
domains (Gly1–Arg55 and Lys56–Met106), each of which
Figure 7. Suppression of SLPI Expression by IFNg preserves thespacing of eightcysteine residues charac-
Northern blot with total RNA (20 mg per lane) from RAW264.7 cells teristic of human SLPI (Seemuller et al., 1986). In human
that had been treated in the presence or absence of LPS (100 ng/ SLPI, all 16 cysteines are engaged in interdomain disul-
ml) or IFNg (10 U/ml) for 4 hr was probed with mouse SLPI cDNA.
fide links (Grutter et al., 1988). A four disulfide core isThe same membrane was reblotted using b-actin oligonucleotide
thought to stabilize a molecule that lacks a hydrophobicprobe as a control.
core and has little hydrogen-bonded secondary struc-
ture (Drenth et al., 1980). Another hallmark of human
SLPI is the abundance of proline (12 per 107 residues),3A and 4A). Whether the additional band represents a
with Pro76-Pro77 adopting a polyproline II-like conforma-splicing variant has not yet been established.
tion. Of the 11 prolines in mouse SLPI, 9 reside at corre-
sponding positions, including those homologous toSuppression of SLPI Expression by IFNg
Pro76-Pro77. Thus, it is likely that secreted mouse SLPI
Many differentiative effects of LPS on macrophages are
adopts the same structure as its human counterpart.
mimicked or augmented by cotreatment with IFNg. How-
However, there may be important differences. X-ray
ever, because IFNg augmented LPS responses in SLPI-
crystallography (Grutter et al., 1988) and mutagenesis
expressing cells, and because SLPI inhibits LPS re-
analysis (Eisenberg et al., 1990) identified Leu72-Met73 in
sponses, it was necessary to consider whether IFNg
human SLPI as the reactive site for inhibition of elastase,
might decrease the expression of SLPI, even though
trypsin, and chymotrypsin. In mouse SLPI, the corre-
LPS itself had the opposite effect. As shown in Figure
sponding residues are Met73-Met74. In addition, human
7, exposure of RAW 264.7 cells to LPS led to increased
SLPI binds some target proteases through the residues
levels of SLPI mRNA, while treatment with IFNg inhibited
TYGQCLML at positions 67–74 plus Met-Cys at 96–97.
both the basal and LPS-induced expression of SLPI.
Mouse SLPI replaces these contacts with TQARCMML
(amino acids 68–75), and substitutes Ile for Met at resi-
Discussion due 96. We have been unable to express recombinant
SLPI in bioactive form, probably because the critical
Mouse SLPI can now be considered a phagocyte- sulfhydryls are susceptible to oxidation and incorrect
derived LPS-induced LPS inhibitor. New sources, func- disulfide bonding (Stolk et al.,1993; Tomova et al., 1994).
tions, and modes of regulation are surprising additions Thus, we have not yet been able to test if the differences
to the understandingof a protein whose human homolog in primary sequence abolish the antiprotease function
has been so intensively studied. of mouse SLPI, or, conversely, adapt mouse SLPI to
mouse proteases. The latter possibility is favored by the
SLPI: Sources and Structures inability of recombinant human SLPI to inhibit mouse
Human SLPI, cloned a decade ago at the cDNA and PMN elastase while displaying potent inhibitory activity
genomic levels (Heinzel et al., 1986; Seemuller et al., toward human PMN elastase in the same experiments
1986; Stetler et al., 1986), is an 11.7 kDa protein originally (A. D., unpublished data).
isolated from parotid saliva (Thompson and Ohlsson,
1986). Human SLPI was subsequently found in seminal SLPI: Possible Relation to the Lps Gene
plasma (Ohlsson et al., 1995) and cervical (Helmig et al., In the virtual absence of LPS, the macrophage cell line
1995), nasal, and bronchial (Hutchison, 1987; Lee et al., of C3H/HeJ (Lpsd ) origin overexpressed SLPI compared
1993) mucus. SLPI was named for its location in secre- to the companion macrophage line from C3H/HeN (Lpsn )
tions and its actions as a potent inhibitor of leukocyte mice. On the other hand, primary macrophages and
serine proteases, notably elastase and cathepsin G from PMN from both strains expressed SLPI. Interpretation
neutrophils, and chymase and tryptase from mast cells, of the latter result is complicated by the fact that the
as well as trypsin and chymotrypsin from pancreatic cells were collected from mice after they were exposed
acinar cells (Fink et al., 1986; Thompson and Ohlsson, to LPS as a contaminant in thioglycollate broth. Even
1986; Ohlsson et al., 1988). cells from conventionally reared mice not injected with
Thus, the term “leukocyte” in SLPI’s name refers to LPS can be expected to have encountered LPS through
the source of some of the proteases it inhibits; SLPI natural routes. Thus, SLPI may have been expressed
itself has been considered exclusively an epithelial cell for the most part constitutively in C3H/HeJ (Lpsd ) phago-
product (Abe et al., 1991), except for one report of its cytes, but may have been induced by LPS in C3H/HeN
expression in human neutrophils (Bohm et al., 1992). In (Lpsn ) cells. Studies in axenic mice will be necessary to
mouse, we found SLPI transcript and protein in splenic resolve this issue.
adherent cells, peritoneal macrophages, bone marrow- Cloning SLPI cDNA from a RAW 264.7 cell library al-
lowed us to clone the open reading frame by RT-PCRderived macrophage cell lines, and peritoneal PMN.
SLPI as an LPS Inhibitor
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from C3H/HeJ and C3H/HeN cells, and establish that IFNg as a full macrophage-activating signal (Ding et al.,
1987; Ingalls and Golenbock, 1995). Perhaps secretedall three coding sequences are identical (F.-y. J., unpub-
lished data). Moreover, our cloning of genomic mouse SLPI, which can bind to some extracellular matrices
(Kramps et al., 1989), blocks a costimulatory role servedSLPI has permitted us to exclude its localization on
chromosome 4 (A. D., unpublished data). Thus, SLPI is by integrins in macrophage responsiveness to LPS.
Consistent with this speculation, our SLPI-expressingnot the product of the Lps gene, but regulation of SLPI
could be affected by allelic forms of Lps. Consistent transfectants were less adherent than the SLPI-nonex-
pressing parental cells or control transfectants (Jin,with this speculation is that IFNg corrects both the Lpsd-
encoded defect and the LPS-inhibitory action of SLPI. F.-y. J., unpublished data).
Finally, SLPI may function by engaging a membraneThat IFNg suppresses expression of SLPI provides one
possible explanation of the basis by which IFNg normal- receptor to induce an LPS-antagonistic signal. SLPI’s
three-dimensional structure suggests that it belongs toizes responses to LPS in C3H/HeJ (Lpsd ) mice.
a protein family populated largely by neurotoxins that
share equivalently placed loops held together by four
SLPI: Regulation, Functions, and Mechanisms similarly positioned disulfide bonds (Drenth et al., 1980).
SLPI isone of the few genes whoseexpression in macro- Where studied, these functionally divergent proteins all
phages is induced by LPS and suppressed by IFNg. In act by specific binding to membrane receptors. That
human epithelial cells, SLPI was constitutively ex- SLPI may bind to macrophages is consonant with the
pressed and its expression was increased by phorbol view that salivary SLPI blocks infectivity of HIV by first
ester, TNFa, and LPS at supraphysiologic concentra- binding to monocytes (McNeely et al., 1995).
tions (10 mg/ml) (Maruyama et al., 1994; Sallenave et al., The inhibitory effect of SLPIon LPS-induced secretion
1994), as well as by synergistic combinations of elastase of NO and TNFa is likely to reflect interference with early
and corticosteroids (Abbinante-Nissen et al., 1993, steps of signaling. NF-kB/rel binding site(s) serve as
1995). Despite the cloning of the human SLPI gene, we LPS-response elements in the promoters of many LPS-
are not aware of any studies of its promoter. Our cloning inducible genes, including the two whose products are
of the mouse SLPI promoter (A. D., unpublished data) monitored here, i.e., inducible NO synthase and TNFa
will aid in understanding the unusual antagonistic rela- (Xie et al., 1994; Sweet and Hume, 1996). Activation of
tionship between LPS and IFNg. the NF-kB complex was inhibited in SLPI-overexpress-
It remains to be determined by what mechanism SLPI ing GG2EE (Lpsd ) cells and SLPI-transfected HeNC2
inhibits macrophage responses to LPS. The proclivity (Lpsn ) cells.
of SLPI to undergo oxidative inactivation (Stolk et al., SLPI accounts for 80%–90% of the elastase-inhibitory
1993) may explain why transfection with SLPI cDNA capacity of bronchial secretions (Tegner, 1978). Admin-
revealed its new biological actions, whereas no inhibi- istration of SLPI can protect animals from emphysema
tion of LPS responses followed incubation of SLPI-non- induced by neutrophil elastase or by LPS (Lucey et al.,
producing cellswith SLPI producers or their conditioned 1990; Rudolphus et al., 1993). LPS-induced expression
medium (unpublished data). of SLPI in PMN suggests the existence of a feedback
Inhibition of LPS responses may be a consequence of mechanism in inflammatory reactions, whereby LPS, a
SLPI’s antiprotease action.This hypothesis isconsistent major stimulus for recruitment of PMN, elicits from PMN
with the findings that serine protease inhibitor diisopro- an inhibitor of some of the major tissue-damaging en-
pylfluorophosphate blocked LPS-induced proliferation zymes that they import.
of B cells (Ku et al., 1981), while trypsin partially normal- Identification of SLPI as an LPS-induced LPS inhibitor
ized this response in B cells from C3H/HeJ mice (Kuus- raises the possibility that SLPI may be involved in the
Reichel and Ulevitch, 1986). Moreover, treatment of hu- phenomenon of LPS tolerance; that is, the ability of an
man neutrophils or endothelial cells with urinary trypsin initial exposure to LPS to cause relative refractoriness
inhibitor, a 25 kDa stress-induced fragment of the to a subsequent exposure (Beeson, 1947). Other candi-
plasma protein inter-a trypsin inhibitor, blocked the abil- dates to mediate LPS tolerance include glucocorticoids
ity of LPS to trigger an elevation of intracellular Ca21; (Beutler et al., 1986a; Hogan and Vogel, 1988), IL-10
similar effects were seen with the isolated protease- (Bogdan et al., 1991; Randow et al., 1995), and TGF-b
inhibitory domain or with synthetic peptides encom- (Ding et al., 1990; Randow, et al., 1995). A role for SLPI
passing the trypsin inhibitory site (Kanayama et al., as a mediator of glucocorticoid action in LPS tolerance
1995). Like SLPI, urinary trypsin inhibitor isactive against can be envisioned, since tolerogenic doses of LPS ele-
neutrophil elastase and cathepsin G, as well as trypsin vate plasma glucocorticoids, and glucocorticoids in-
and chymotrypsin. creased human SLPI transcripts inhuman airwayepithe-
Alternatively, SLPI’s action as an LPS inhibitor may be lial cells (Abbinante-Nissen et al., 1995). If plasma levels
independent of its antiproteolytic function. Plasminogen of SLPI increase in septic states, as our findings would
activator inhibitor-1 (PAI-1), another serine protease in- predict, then SLPI may be one of the unidentified factors
hibitor, blocked cell migration by nonproteolytically dis- in septic shock patients’ plasma that suppresses mono-
placing cells’ integrins from their attachment to vitro- cyte responsiveness to LPS (Brandtzaeg et al., 1996).
nectin in the extracellular matrix (Deng et al., 1996;
Stefansson and Lawrence, 1996). Integrinscan influence
Experimental Proceduresmacrophage responsiveness to LPS and can serve as
cofactors for macrophage activation by other agents Materials
(Wright and Jong, 1986; Yurochko et al., 1992). When Reagents and supplies were obtained as follows: LPS prepared by
phenol extraction from List Biological Laboratories (Campbell, CA);cross-linked by antibodies, integrins can even mimic
Cell
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mouse IFNg (protein concentration 1.1 mg/ml; sp. act. 5.2 3 106 Products, Boston, MA). The membrane was hybridized for 18 hr at
428C with labeled probe (106 cpm/ml) in 5 3 SSC, 5 3 DenhartU/mg; LPS content ,10 pg/ml) from Genentech (South San Fran-
cisco, CA); oligonucleotide primers from Oligo Etc., Inc. (Guilford, buffer, 50% formamide, and 1% SDS plus 100 mg/ml of sperm DNA.
Membranes were then washed twice with 1 3 SSC, 0.1% SDS (10CT); G418, reverse transcription buffer, and Moloney murine leuke-
mia virus reverse transcriptase from Gibco Life Technologies (Grand min, room temperature), and with 0.25 3 SSC, 0.1% SDS (10 min,
558C) before autoradiography.Island, NY); restriction enzymes from New England Biolabs (Beverly
MA); AmpliTaq DNA polymerase, dNTPs, and PCR buffer solutions
from Perkin Elmer Cetus (Foster City, CA); guanidium isothiocya- cDNA Cloning
nate, formaldehyde, and formamide from Fluka Chemica-Bio- Subcloned cDNA fragment from differential display was used as a
chemica (Ronkonkoma, NY); and all other reagents from Sigma (St. probe to screen for full-length cDNA from a customized RAW 264.7
Louis, MO) except as specified below. Tissue culture dishes were macrophage cDNA library in a lambda phage ZAP vector (Stra-
from Corning Glass Works (Corning, NY). tagene, La Jolla, CA) according to the instruction manual provided
by the supplier.
Mice
Charles River Breeding Laboratories (Wilmington, MA) and Jackson Generation of Antibody to Recombinant Protein
Laboratories (Bar Harbor, ME) supplied C3H/HeN (Lpsn ) and C3H/ A SLPI cDNA fragment (BamHI–XhoI: 495–1123) coding for the last
HeJ (Lpsd ) female mice, respectively. ten amino acids of the signal peptide and full-length secreted SLPI
was subcloned into pQE32 vector (Qiagen, Chasworth, CA) for a
fusion protein with hexahistidine attached to the N-terminus. M15Cells
cells were transformed with this plasmid and grown in 1 l LB at 378CCells were maintained in RPMI 1640 supplemented with 10% heat-
with ampicillin (100 mg/ml) and kanamycin (25 mg/ml) to OD600 5 0.7.inactivated fetal bovine serum (HyClone, Logan, UT), 2 mM L-gluta-
The bacterial pellet was collected 4 hr after IPTG (1 mM) inductionmine, 200 units/ml penicillin, and 200 mg/ml streptomycin at 378C
and sonicated in 20 ml of sonication buffer (50 mM Na-phosphatein 5% CO2/95% air. Complete culture medium was routinely moni-
[pH 8.0], 300 mM NaCl, 1 mg/ml lysozyme). The pellet (13,000 3 g,tored for LPS contamination by the chromogenic limulus amebocyte
30 min) was resuspended in 20 ml of denaturing buffer (6 M guanidi-lysate assay (BioWhittaker, Walkersville, MD), and found to contain
nium HCl, 0.1 M Na-phosphate, 0.01 M Tris-HCl [pH 8.0], 10 mM,25 pg LPS/ml. ANA-1 cells were kindly provided by Dr. L. Varesio
b-mercaptoethanol) for 1 hr at room temperature. The supernate(NCI, Frederick, MD). ANA-1, HeNC2, and GG2EE cells are bone
(10,000 3 g,15 min at 48C) was stirredfor 60min at room temperaturemarrow-derived J2 virus-transformed macrophage cell lines, ac-
with 5 ml of 50% slurry of Ni1-NTA resin, and the resin was washedcording to the method described previously (Blasi et al., 1987; Cox
with 10 vol denaturing buffer and 10 vol of washing buffer I (8 Met al., 1989). J774.1 was provided by D. Falcone (Cornell University
urea, 0.1 M Na-phosphate, 0.01 M Tris-HCl [pH 8.0], 10 mMMedical College, NY). HeNC2 cells stably transfected with p463-
b-mercaptoethanol), followed by washing buffer II (washing bufferneo-SLPI or p463-neo vectors were maintained in 500 mg/ml G418.
I [pH 6.3]) until OD280 of the wash was ,0.01. Recombinant proteinRAW 264.7 cells were from American Type Culture Collection (Rock-
was eluted with 10 ml of washing buffer II plus 250 mM imidazoleville, MD). Primary mouse macrophages and PMN were collected
and sequenced by Edman degradation (Microbiological Associates,from the peritoneal cavity 4 and 0.5 days, respectively, after intra-
Rockville, MD) to confirm identity and purity. SDS-gel slices con-peritoneal injection with 2 ml of 4% Brewer’s thioglycollate broth
taining 100 mg purified protein were emulsified with Freund’s com-(DIFCO, Detroit, MI). Spleens from the mice were minced and tritu-
plete adjuvant for injection in rabbits.rated through an 18-gauge needle. Nonadherent splenocytes were
collected after 2 hr culture in flat vessels to deplete adherent cells.
Immunoprecipitation and Western Blot
Cells were cultured for two days at 106 per 2 ml per 36 mm–diamDifferential Display
well. Anti-mouse SLPI antiserum (1:1000) and immobilized proteinCultured HeNC2 (Lpsn ) and GG2EE (Lpsd ) cells were lysed with 4 M
A beads (Pierce, Rockford, IL) were incubated with the collectedguanidinium isothiocyanate. The cell lysate was layered on 5.7 M
medium overnight at 48C. Beads were washed with buffer TBS (25CsCl, 0.1 M EDTA, and centrifuged at 35,000 3 g at 48C for 14 hr
mM Tris [pH 7.5], 150 mM NaCl) with 0.5% NP40, 0.5% Triton X-100,in an SW-40 rotor in an L8-M ultracentrifuge (Beckman, Palo Alto,
1.5 mM MgCl2, and 10% glycerol, followed by TBS. Immunoprecipi-CA). The RNA pellet was dissolved in 0.1% diethyl pyrocarbonate-
tates were boiled for 5 min in reducing SDS-PAGE sample buffertreated H2O and subjected to digestion with DNase I (1 unit/ml,
and subjected to SDS-PAGE. Proteins were transferred to a 0.20RNase-free) (GIBCO Life Technologies, Grand Island, NY) for 30 min
mm–pore nitrocellulose membrane (Schleicher and Shuell, Inc.,at 378C. Digested RNA was extracted with phenol/chloroform and
Keene, NH) in 20% methanol, 25 mM Tris, and 192 mM glycine (pHprecipitated with ethanol.
8.3). The membrane was blocked with 5% milk and blotted withFor differential display (Liang et al., 1993), 1 mg DNA-free total
anti-mouse SLPI antiserum (1:1,000), followed by goat anti-rabbit-RNA was used for the reverse transcription reaction (final volume,
IgG coupled to horseradish peroxidase (1:10,000) (Amersham, Ar-20 ml) with 20 mM dNTPs, 0.8 u/ml RNAsin (Promega), and 1 mM
lington Hights, IL). The bound antibody was detected by ECL (NENprimer T12MC at 658C, 5 min at 378C, 60 min at 958C, and 5 min
Research Products, Boston, MA).at 48C. Reverse transcriptase (100 units) was added after 10 min
incubation at 378C. PCR reaction was performed (final volume, 20
ml) with PCR buffer II, 2.5 mM MgCl2, 2 mM dNTPs, 0.2 mM primer Assays for Secretion of NO22 and TNFa
ACCATGGACT, 1 mM T12MC, 2 ml reverse transcription mix, 1 ml Cells were plated in 96-well plates at 105 cells per well in 100 ml of
35S-dATP (1200 Ci/mmol) (NEM LifeScience Products, Boston, MA), medium and treated 24 hr or 48 hr with indicated concentrations of
and 1 unit AmpliTaq polymerase at 948C, 30 s at 408C, 2 min at LPS, IFNg, or both. Conditioned medium (100 ml) was mixed with
728C, 30 s for 40 cycles at 728C, and 5 min at 48C. Samples (4 ml) equal volume of Greiss’s reagent (1% sulfanilamide, 0.1% naph-
were run on 6% sequencing gels. Differentially expressed products thylethylenediamine dihydrochloride, 2.5% H3PO4). Absorbance at
were extracted with H2O and reamplified twice in the PCR reaction 550 nm was recorded in a microplate reader (MR5000, Dynatech,
using the same set of primers. The reamplified PCR product was Chantilly, VA) with sodium nitrite standards. Nitrite content of simi-
subcloned into PCR AT cloning vector (Invitrogen, San Diego, CA), larly incubated cell-free medium was subtracted. For TNFa ELISA
and sequenced. (Duoset, Genzyme, Cambridge, MA), culture supernatant was col-
lected at 12 hr or 24 hr and tested according to the manufacturer’s
instructions.Northern Blot
20 mg of total RNA was run on a 1% agarose gel with 0.2 M 3-[N-
morpholino] propanesulfonic acid (pH 7.0), 0.5 M sodium acetate, Generation of Stable Transfectants
p463-Neo, a pUC19-based vector, was generated by combining the10 mM EDTA (1 3 MOPS), and 2% formaldehyde, confirming equal
loading by means of staining with 2.5 mg/ml ethidium bromide. RNA spleen focus-forming virus LTR from pFNeo with theBamHI to EcoRI
fragment of the human growth hormone. The hGH sequences andwas transferred in 20 3 SSC onto nylon membrane (NEN) (Research
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Coutinho, A., Gronowicz, E., and Sultzer, B.M. (1975). Genetic con-polyadenylation signals were added to increase mRNA stability for
trol of B-cell responses. I. Selective unresponsiveness to lipopoly-cDNA expression (Costa et al., 1992). The vector was ligated with
saccharide. Scand. J. Immunol. 4, 139–143.mouse SLPI cDNA Ecl136III-NaeI fragment (435 bp including open
reading frame) to generate the plasmid p463-Neo-SLPI. Plasmid Cox, G., Grandino, L., Blasi, E., Radzioch, D., Mathieson, B.J., and
p463-Neo-SLPI and the vector control plasmid p463-Neo were Varesio, L. (1989) Heterogeneity of hematopoietic cells immortalized
transfected into HeNC2 (Lpsn ) cells using N-[1-(2, 3-dioleoyloxy)pro- by v-myc/v-raf recombinant retrovirus infection of bone marrow or
pyl]-N,N,N-trimethylammonium methylsulfate (DODAP, Boehringer fetal liver. J. Natl. Cancer Inst. 81, 1492–1496.
Mannheim). After two weeks of selection in G418 (500 mg/ml), ex- Deng, G., Curriden, S.A., Wang, S., Rosenberg, S., and Loskutoff,
panded cells were subjected to limiting dilution in the presence of D.J. (1996). Isplasminogen activator inhibitor-1 the molecularswitch
feeder cells (murine resident peritoneal cells) to select individual that governs urokinase receptor-mediated cell adhesion and re-
stable transfectants. lease? J. Cell Biol. 134, 1563–1571.
De Water, R., Willems, L.N., Van Muijen, G.N., Franken, C., Fransen,
Electrophoretic Mobility Shift Assays (EMSA) J.A., Dijkman, J.H., and Kramps, J.A. (1986). Ultrastructural localiza-
Cells were treated with LPS or IFNg. NF-kB or GRR binding activities tion of bronchial antileukoprotease in central and peripheral human
in the nuclear extracts were determined as described (Pearse et al., airways by a gold-labeling technique using monoclonal antibodies.
1991; Xie et al., 1994). Am. Rev. Respir. Dis. 133, 882–890.
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saccharide prevent interferon-gamma or tumor necrosis factor-Acknowledgments
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